These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 20713668)

  • 21. Improvement of respiratory symptoms and health-related quality of life with peramivir in influenza patients with chronic respiratory disease: Additional outcomes of a randomized, open-label study.
    Kato M; Saisho Y; Tanaka H; Bando T
    Influenza Other Respir Viruses; 2021 Sep; 15(5):651-660. PubMed ID: 33683019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: Findings of a randomized, open-label study.
    Kato M; Saisho Y; Tanaka H; Bando T
    Influenza Other Respir Viruses; 2021 Jan; 15(1):132-141. PubMed ID: 32677375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Economic model for emergency use authorization of intravenous peramivir.
    Lee BY; Tai JH; Bailey RR; McGlone SM; Wiringa AE; Zimmer SM; Smith KJ; Zimmerman RK
    Am J Manag Care; 2011 Jan; 17(1):e1-9. PubMed ID: 21485418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peramivir for the treatment of influenza.
    Shetty AK; Peek LA
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):123-43. PubMed ID: 22339187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of intravenous peramivir for treatment of influenza in hospitalized patients.
    de Jong MD; Ison MG; Monto AS; Metev H; Clark C; O'Neil B; Elder J; McCullough A; Collis P; Sheridan WP
    Clin Infect Dis; 2014 Dec; 59(12):e172-85. PubMed ID: 25115871
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection.
    Sugaya N; Kohno S; Ishibashi T; Wajima T; Takahashi T
    Antimicrob Agents Chemother; 2012 Jan; 56(1):369-77. PubMed ID: 22024821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of delayed treatment of China-made Peramivir with repeated intravenous injections in a mouse influenza model: from clinical experience to basal experiment.
    Li Z; Li R; Li J; Xie H; Hao Y; Du Q; Chen T; Li Y; Chen R; Yang Z; Zhong N
    BMC Infect Dis; 2016 Jul; 16():325. PubMed ID: 27392915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A randomized controlled study of peramivir, oseltamivir and placebo in patients with mild influenza].
    Fan HW; Han Y; Liu W; Li XW; Li LZ; Yao HY; Wang Y; Su ZQ; Ye WX; Huang J; Lu WZ; Li GW; Li HL; Wang SY; Wu H; Lu QF; Zhu GF; Liu SM; Chen G; Zhang WH; Li TS
    Zhonghua Nei Ke Za Zhi; 2019 Aug; 58(8):560-565. PubMed ID: 31365976
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical efficiency in children treated with intravenous drip infusion of peramivir].
    Sakata H
    Jpn J Antibiot; 2011 Dec; 64(6):383-7. PubMed ID: 22686008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.
    Tarbet EB; Maekawa M; Furuta Y; Babu YS; Morrey JD; Smee DF
    Antiviral Res; 2012 Apr; 94(1):103-10. PubMed ID: 22429564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prophylactic activity of intramuscular peramivir in mice infected with a recombinant influenza A/WSN/33 (H1N1) virus containing the H274Y neuraminidase mutation.
    Abed Y; Simon P; Boivin G
    Antimicrob Agents Chemother; 2010 Jul; 54(7):2819-22. PubMed ID: 20404128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
    Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to several recent publications related to safety and efficacy of peramivir from the emergency use authorization experience.
    Ison MG; Hollister AS; Sheridan WP
    Clin Infect Dis; 2013 Jan; 56(1):164. PubMed ID: 22972863
    [No Abstract]   [Full Text] [Related]  

  • 34. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir. II: a pediatric drug use investigation.
    Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2015 Mar; 21(3):194-201. PubMed ID: 25523716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1).
    Yun NE; Linde NS; Zacks MA; Barr IG; Hurt AC; Smith JN; Dziuba N; Holbrook MR; Zhang L; Kilpatrick JM; Arnold CS; Paessler S
    Virology; 2008 Apr; 374(1):198-209. PubMed ID: 18234269
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.
    Komeda T; Ishii S; Itoh Y; Ariyasu Y; Sanekata M; Yoshikawa T; Shimada J
    J Infect Chemother; 2014 Nov; 20(11):689-95. PubMed ID: 25131292
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Retrospective Analysis of Three Antiviral Regimens of Peramivir in the Treatment of Severe Influenza A with Primary Viral Pneumonia.
    Wang JN; Wang X; Yu SL; Ding YH; Wang ML; Chen HD
    Can Respir J; 2019; 2019():3859230. PubMed ID: 31182983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of peramivir in adult patients with seasonal influenza during the winter of 2012 in Japan.
    Yoshino Y; Seo K; Koga I; Kitazawa T; Ota Y
    Clin Respir J; 2015 Apr; 9(2):228-32. PubMed ID: 24612842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune response after a single intravenous peramivir administration in children with influenza.
    Sato M; Hashimoto K; Kawasaki Y; Hosoya M
    Antivir Ther; 2018; 23(5):435-441. PubMed ID: 29372885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-influenza virus activity of peramivir in mice with single intramuscular injection.
    Bantia S; Arnold CS; Parker CD; Upshaw R; Chand P
    Antiviral Res; 2006 Jan; 69(1):39-45. PubMed ID: 16325932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.